Show Summary Details
Page of

Nimodipine for Subarachnoid Hemorrhage 

Nimodipine for Subarachnoid Hemorrhage
Nimodipine for Subarachnoid Hemorrhage

Teddy S. Youn

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 15 July 2020

This chapter provides a summary of a landmark study in neurocritical care. Does nimodipine prevent or alter the severity of ischemic neurologic deficits due to vasospasm in patients with aneurysmal subarachnoid hemorrhage? Starting with that question, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. This double-blind randomized controlled trial established that oral nimodipine is a part of standard treatment for awake patients with aneurysmal subarachnoid hemorrhage. The chapter briefly reviews other relevant studies and information, and concludes with a relevant clinical case.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.